{
    "eid": "2-s2.0-85116350665",
    "title": "Quantification of CYP3A and Drug Transporters Activity in Healthy Young, Healthy Elderly and Chronic Kidney Disease Elderly Patients by a Microdose Cocktail Approach",
    "cover-date": "2021-09-17",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "chronic kidney disease",
        "cytochrome P450",
        "drug transporters",
        "elderly",
        "microdose cocktail",
        "pharmacokinetics"
    ],
    "authors": [
        "Punyabhorn Rattanacheeworn",
        "Stephen J. Kerr",
        "Wonngarm Kittanamongkolchai",
        "Natavudh Townamchai",
        "Suwasin Udomkarnjananun",
        "Kearkiat Praditpornsilpa",
        "Thanundorn Thanusuwannasak",
        "Udomsak Udomnilobol",
        "Suree Jianmongkol",
        "Boonsri Ongpipattanakul",
        "Thomayant Prueksaritanont",
        "Yingyos Avihingsanon",
        "Pajaree Chariyavilaskul"
    ],
    "citedby-count": 7,
    "ref-count": 58,
    "ref-list": [
        "Pitavastatin: Evidence for its Place in Treatment of Hypercholesterolemia",
        "The Concise Guide to Pharmacology 2017/18: Overview",
        "American Geriatrics Society 2019 Updated AGS Beers Criteria\u00ae for Potentially Inappropriate Medication Use in Older Adults",
        "Pharmacology of Dormicum (Midazolam) and Anexate (Flumazenil)",
        "The Metabolism and Disposition of the Oral Direct Thrombin Inhibitor, Dabigatran, in Humans",
        "Dabigatran Etexilate and Digoxin: Comparison as Clinical Probe Substrates for Evaluation of P-Gp Inhibition",
        "Polypharmacy: a Global Risk Factor for Elderly People",
        "Rosuvastatin in Elderly Patients",
        "Prolonged Midazolam Elimination Half-Life",
        "Pharmacokinetic-pharmacodynamic Crisis in the Elderly",
        "Assessment of Pharmacokinetic Drug-Drug Interactions in Humans: In Vivo Probe Substrates for Drug Metabolism and Drug Transport Revisited",
        "Membrane Transporters in Drug Development",
        "Effect of Age and Gender on Pharmacokinetics of Atorvastatin in Humans",
        "Genotype-phenotype Associations of Cytochrome P450 3A4 and 3A5 Polymorphism with Midazolam Clearance In Vivo",
        "Effects of Atorvastatin Metabolites on Induction of Drug-Metabolizing Enzymes and Membrane Transporters through Human Pregnane X Receptor",
        "ATP-dependent Transport of Rosuvastatin in Membrane Vesicles Expressing Breast Cancer Resistance Protein",
        "Changes in Pharmacokinetics and Pharmacodynamics in the Elderly Patient",
        "Prevalence and Risk Factors of Chronic Kidney Disease in the Thai Adult Population: Thai SEEK Study",
        "Organic Ion Transporters and Statin Drug Interactions",
        "The National Lipid Association's Safety Task, F.A Clinician's Guide to Statin Drug-Drug Interactions",
        "ABCG2 Polymorphism Markedly Affects the Pharmacokinetics of Atorvastatin and Rosuvastatin",
        "Influence of OATP1B1 and BCRP Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Rosuvastatin in Elderly and Young Korean Subjects",
        "Pharmacokinetics and Drug Metabolism in the Elderly",
        "Genetic Contribution to Variable Human CYP3A-Mediated Metabolism",
        "Human Intestinal P-Glycoprotein Activity Estimated by the Model Substrate Digoxin",
        "Effects of Polymorphisms in ABCG2, SLCO1B1, SLC10A1 and CYP2C9/19 on Plasma Concentrations of Rosuvastatin and Lipid Response in Chinese Patients",
        "The Effect of Cytochrome P450 Metabolism on Drug Response, Interactions, and Adverse Effects",
        "No Effect of Age or Gender on the Pharmacokinetics of Rosuvastatin: a New HMG-CoA Reductase Inhibitor",
        "Phenotype Prediction and Characterization of 25 Pharmacogenes in Thais from Whole Genome Sequencing for Clinical Implementation",
        "Association of Genotypes of the CYP3A Cluster with Midazolam Disposition In Vivo",
        "Comparison of the Safety, Tolerability, and Pharmacokinetic Profile of a Single Oral Dose of Pitavastatin 4 Mg in Adult Subjects with Severe Renal Impairment Not on Hemodialysis versus Healthy Adult Subjects",
        "Dabigatran: A New Oral Anticoagulant. Guidelines to Follow in Oral Surgery Procedures. A Systematic Review of the Literature",
        "Down-regulation of Intestinal Drug Transporters in Chronic Renal Failure in Rats",
        "Effects of Chronic Renal Failure on Liver Drug Transporters",
        "Emerging Evidence of the Impact of Kidney Disease on Drug Metabolism and Transport",
        "The Need for Robust Validation for MDRD-Based Glomerular Filtration Rate Estimation in Various CKD Populations",
        "Pitavastatin Is a More Sensitive and Selective Organic Anion-Transporting Polypeptide 1B Clinical Probe Than Rosuvastatin",
        "Validation of a Microdose Probe Drug Cocktail for Clinical Drug Interaction Assessments for Drug Transporters and CYP3A",
        "The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin-Induced Myopathy: 2014 Update",
        "SLCO1B1 and ABCG2 Gene Polymorphisms in a Thai Population",
        "The Influence of SLCO1B1 (OATP1B1) Gene Polymorphisms on Response to Statin Therapy",
        "Clinical Importance of OATP1B1 and OATP1B3 in Drug-Drug Interactions",
        "Impact of CYP3A5 and CYP3A4 Gene Polymorphisms on Dose Requirement of Calcineurin Inhibitors, Cyclosporine and Tacrolimus, in Renal Allograft Recipients of North India",
        "Effects of Renal Failure on Drug Transport and Metabolism",
        "Use of Physiologically Based Pharmacokinetic Modeling to Evaluate the Effect of Chronic Kidney Disease on the Disposition of Hepatic CYP2C8 and OATP1B Drug Substrates",
        "A Microdose Cocktail to Evaluate Drug Interactions in Patients with Renal Impairment",
        "A Microdose Cocktail to Evaluate Drug Interactions in Patients with Renal Impairment",
        "Drug Disposition Issues in CKD: Implications for Drug Discovery and Regulatory Approval",
        "Effect of Chronic Renal Failure on the Expression and Function of Rat Intestinal P-Glycoprotein in Drug Excretion",
        "Sex-based Differences in Drug Activity",
        "Effects of Chronic Kidney Disease and Uremia on Hepatic Drug Metabolism and Transport",
        "Role of BCRP 421C>A Polymorphism on Rosuvastatin Pharmacokinetics in Healthy Chinese Males",
        "Worldwide Distribution of Cytochrome P450 Alleles: A Meta-Analysis of Population-Scale Sequencing Projects"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Maha Chakri Sirindhorn Clinical Research Center",
        "Chulalongkorn University",
        "Health Systems Research Institute"
    ]
}